Sensus Healthcare is dedicated to improving the lives of men and women who suffer from skin cancer. We believe every patient deserves a choice. It’s the reason we offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiation Therapy using the SRT-100™️. Today, nearly five million people in the United States are treated for skin cancer, with four million new cases of basal and squamous cell (non-melanoma) skin cancer diagnosed each year. Treatment often involves invasive incisions that damage healthy tissue, painful healing, lengthy recovery and unsightly scarring that takes an emotional toll on patients. Sensus Healthcare is changing all that.
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless.
Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it doesn’t involve cutting, bleeding or stitching. With the SRT-100™️, there is no need for anesthesia, no risk of infection or scarring, no need for reconstructive plastic surgery. Patients heal quickly and don’t have downtime or lifestyle restrictions following treatment.
Sensus Healthcare’s SRT-100™️ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare providers.